What Does Brain Atrophy Look Like on MRI?

Brain atrophy on MRI shows up as a shrinking brain with more visible gaps and fluid-filled spaces than expected for a person’s age. The most recognizable signs are widened grooves (sulci) on the brain’s surface, enlarged fluid-filled chambers (ventricles) in the center, and a thinner outer layer of brain tissue. These changes are visible even to a non-specialist looking at the images, though radiologists use standardized scales to grade their severity.

The Key Visual Signs

A healthy brain on MRI fills the skull snugly, with narrow grooves between its folds and relatively small ventricles. When atrophy is present, the brain essentially pulls away from the skull, and fluid fills the space left behind. There are four hallmark changes that radiologists look for.

Sulcal widening is often the first thing that catches the eye. The sulci are the grooves between the brain’s folds, and as brain tissue shrinks, these grooves become wider and more prominent. On an MRI, they appear as dark lines (on T1-weighted images) that are noticeably broader than normal.

Ventricular enlargement is one of the most prominent features of an atrophying brain. The ventricles are fluid-filled cavities deep inside the brain, and they expand as the surrounding tissue loses volume. On MRI, they appear as bright white spaces (on T2 or FLAIR sequences) that balloon outward. In advanced atrophy, the lateral ventricles can become dramatically oversized compared to a healthy scan.

Cortical thinning refers to the outer layer of the brain (the cortex) becoming measurably thinner. In a young, healthy brain, the cortex averages about 2.8 mm thick. With atrophy, that can drop to 2.6 mm or less. This change is harder to appreciate with the naked eye on a standard scan but can be mapped precisely with specialized software.

Loss of gyrification means the brain’s folds themselves become less complex and pronounced, giving the surface a somewhat flatter, smoother appearance. This goes hand-in-hand with sulcal widening: as the folds shrink, the spaces between them grow.

Generalized vs. Focal Atrophy

Not all brain atrophy looks the same. The pattern of shrinkage often tells radiologists more than the shrinkage itself, because different diseases attack different regions.

Generalized (global) atrophy affects the brain more or less evenly. The ventricles enlarge symmetrically, sulci widen throughout, and the cortex thins across all lobes. This pattern is common in normal aging and in later stages of Alzheimer’s disease.

Focal atrophy targets specific areas. In Alzheimer’s, the hippocampus, a seahorse-shaped structure deep in the temporal lobe involved in memory, shrinks early and visibly. In behavioral variant frontotemporal dementia, the frontal and anterior temporal lobes show progressive atrophy while the back of the brain looks relatively spared. In semantic variant primary progressive aphasia, atrophy concentrates in the lower and middle temporal lobes. These distinct patterns are a major reason MRI is so useful for narrowing down which condition is causing symptoms.

In multiple sclerosis, the pattern is different again. Gray matter atrophy often starts in deep brain structures like the thalamus and caudate nucleus before spreading to the cortex. One postmortem study found thalamic volume was reduced by 17% in MS patients, with a 22% drop in the density of neurons there. The third ventricle, which sits near these deep structures, tends to widen early, and its width correlates with cognitive test performance. White matter volume also decreases, though at a steadier rate across all disease stages.

How Radiologists Grade Severity

Rather than just saying “atrophy is present,” radiologists use visual rating scales to communicate how much atrophy they see. Two of the most common are the Global Cortical Atrophy (GCA) scale and the Medial Temporal Atrophy (MTA) score.

The GCA scale rates overall brain shrinkage from 0 to 3. Scores of 0 and 1 are generally considered negative for significant atrophy, while scores of 2 and 3 indicate moderate to severe loss. A score of 2 might show clearly widened sulci and mildly enlarged ventricles, while a score of 3 reflects pronounced, unmistakable volume loss throughout.

The MTA score, developed in 1992, zeroes in on the temporal lobe and hippocampus, which makes it especially useful for evaluating Alzheimer’s disease. It runs from 0 to 4, graded by looking at three structures: the choroidal fissure (a narrow gap near the hippocampus), the temporal horn of the lateral ventricle, and the hippocampus itself. At score 0, everything looks normal. Score 1 shows slight widening of the choroidal fissure. By score 2, the temporal horn has also widened and the hippocampus has started to shrink. Score 3 reflects moderate hippocampal volume loss, and score 4 represents severe atrophy of all three landmarks.

Automated software tools have added another layer of precision. FDA-approved programs can segment the brain into dozens of regions, calculate each one’s volume, and compare it to age-matched norms. These tools express volumes as a percentage of total intracranial volume, which accounts for natural differences in head size. They can detect subtle, early changes that a human eye might miss on a standard scan.

Normal Aging vs. Something More

Some degree of brain atrophy is completely normal. After age 40, brain volume declines at roughly 5% per decade, and the rate tends to accelerate after 70. So a 75-year-old’s MRI will naturally show wider sulci and larger ventricles than a 30-year-old’s, and that alone doesn’t signal disease.

What raises concern is atrophy that’s more severe or progressing faster than expected for someone’s age, or that’s concentrated in regions associated with a specific disease. A disproportionately small hippocampus in a 65-year-old with memory complaints, for example, points toward Alzheimer’s rather than normal aging. Radiologists compare the scan against what’s typical for the patient’s age group, which is why age-specific reference ranges matter so much.

Enlarged Ventricles: Atrophy or Pressure?

One important distinction radiologists make is whether enlarged ventricles are the result of brain tissue shrinking (called hydrocephalus ex vacuo) or fluid pressure pushing outward, as in normal pressure hydrocephalus (NPH). These two conditions can look superficially similar because both show big ventricles, but the rest of the picture differs in revealing ways.

When atrophy is the cause, the sulci throughout the brain are also wide, because the brain is shrinking everywhere. On a coronal MRI slice, the angle formed by the roof of the ventricles (the callosal angle) is relatively wide, typically around 111 degrees. The upper parietal sulci remain open and visible.

In NPH, the ventricles are enlarged but the sulci at the top of the brain are paradoxically tight, squeezed by the expanding ventricles pushing brain tissue upward. The callosal angle is significantly smaller, around 87 degrees. The Sylvian fissures (the large grooves on the sides of the brain) are disproportionately widened. This combination, large ventricles with tight upper sulci and wide Sylvian fissures, is known as DESH (disproportionately enlarged subarachnoid-space hydrocephalus) and is a key clue that the problem may be treatable with a shunt rather than being irreversible atrophy.

What Different Diseases Look Like

Each neurodegenerative condition tends to leave a characteristic footprint on MRI, which is why the pattern of atrophy often matters more than the amount.

  • Alzheimer’s disease: Early and prominent hippocampal shrinkage, with the temporal horns of the ventricles widening as the surrounding tissue recedes. As the disease progresses, atrophy becomes more generalized, with cortical thinning spreading across the temporal, parietal, and eventually frontal lobes.
  • Behavioral variant frontotemporal dementia: Atrophy concentrated in the frontal lobes and the front portions of the temporal lobes, while the back of the brain remains relatively intact.
  • Semantic variant primary progressive aphasia: Striking asymmetric atrophy of the anterior and inferior temporal lobes, often much worse on one side.
  • Multiple sclerosis: Deep gray matter structures, particularly the thalamus, shrink early. The effect on the thalamus is nearly twice that of any other deep structure. Scattered white matter lesions (bright spots on T2/FLAIR sequences) accompany the volume loss, which helps distinguish MS from other causes.

For any of these conditions, a single MRI provides a snapshot, but serial scans over time are often more informative. Tracking the rate of change reveals whether atrophy is progressing faster than normal aging would explain, which helps clinicians confirm or refine a diagnosis.